Evidence map›Paper›PMID 37059749›Full record

ArticleNPJ Parkinson's disease2023

Aberrant neurophysiological signaling associated with speech impairments in Parkinson's disease.

Alex I Wiesman, Peter W Donhauser, Clotilde Degroot, Sabrina Diab, Shanna Kousaie, Edward A Fon, Denise Klein, Sylvain Baillet, PREVENT-AD Research Group, Quebec Parkinson Network

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. The PREVENT-AD cohort: Accelerating Alzheimer's disease research and treatment in Canada and beyond.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. The neurophysiological brain-fingerprint of Parkinson's disease.medRxiv : the preprint server for health sciences · 2023
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Alex I WiesmanMontreal Neurological Institute, McGill University, 3801 Rue University, Montreal, QC, Canada.
Peter W DonhauserMontreal Neurological Institute, McGill University, 3801 Rue University, Montreal, QC, Canada.
Clotilde DegrootMontreal Neurological Institute, McGill University, 3801 Rue University, Montreal, QC, Canada.
Sabrina DiabDepartment of Psychology, Université du Québec à Montréal, Montréal, QC, Canada.
Shanna KousaieSchool of Psychology, University of Ottawa, Ottawa, ON, Canada.
Edward A FonMontreal Neurological Institute, McGill University, 3801 Rue University, Montreal, QC, Canada.ORCID http://orcid.org/0000-0002-5520-6239
Denise Klein *Montreal Neurological Institute, McGill University, 3801 Rue University, Montreal, QC, Canada. denise.klein@mcgill.ca.ORCID http://orcid.org/0000-0002-6861-8179
Sylvain Baillet *Montreal Neurological Institute, McGill University, 3801 Rue University, Montreal, QC, Canada. sylvain.baillet@mcgill.ca.
PREVENT-AD Research Group
Quebec Parkinson Network
Montreal Neurological Institute and Hospital · CADouglas Mental Health University Institute · CAUniversité du Québec à Montréal · CAUniversity of Ottawa · CA

Funding

BrainStorm: Highly Extensible Software for Advanced Electrophysiology and MEG/EEG ImagingR01EB026299 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LEAHY, RICHARD M · 2018 to 2025
$5.4M
Characterizing the interaction between neural attention and somato-motor systems in non-demented patients with Parkinson's diseaseF32NS119375 · NINDS · MCGILL UNIVERSITY · PI WIESMAN, ALEX I · 2020 to 2023
$205k
Gouvernement du Canada | Canadian Institutes of Health Research (Instituts de Recherche en Santé du Canada) FDN-154301NIBIB NIH HHS R01 EB026299NINDS NIH HHS F32 NS119375U.S. Department of Health & Human Services | National Institutes of Health (NIH) F32-NS119375U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01-EB026299
6 · The paper itself

Abstract

Difficulty producing intelligible speech is a debilitating symptom of Parkinson's disease (PD). Yet, both the robust evaluation of speech impairments and the identification of the affected brain systems are challenging. Using task-free magnetoencephalography, we examine the spectral and spatial definitions of the functional neuropathology underlying reduced speech quality in patients with PD using a new approach to characterize speech impairments and a novel brain-imaging marker. We found that the interactive scoring of speech impairments in PD (N = 59) is reliable across non-expert raters, and better related to the hallmark motor and cognitive impairments of PD than automatically-extracted acoustical features. By relating these speech impairment ratings to neurophysiological deviations from healthy adults (N = 65), we show that articulation impairments in patients with PD are associated with aberrant activity in the left inferior frontal cortex, and that functional connectivity of this region with somatomotor cortices mediates the influence of cognitive decline on speech deficits.

Identifiers

PMID37059749
PMCPMC10104849
OpenAlexW4365514062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.